Ember Therapeutics Inc (EMBT)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 06, 16:00
Ember Therapeutics Cash from Financing (Quarterly): 0.0055M for Sept. 30, 2015
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
September 30, 2015 | 0.0055M |
June 30, 2015 | 0.002M |
March 31, 2015 | 0.0065M |
December 31, 2014 | 0.0011M |
September 30, 2014 | 0.0035M |
June 30, 2014 | 0.008M |
Date | Value |
---|---|
March 31, 2014 | 0.003M |
December 31, 2013 | 0.0045M |
September 30, 2013 | 0.007M |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.01M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
Nutranomics Inc | -0.0007M |
EVIO Inc | 0.0863M |
M2Bio Sciences Inc | -- |
MedCann Industries Inc | -- |
Verde Science Inc | -- |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.006M |